These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7856627)

  • 21. How will drug and device makers fare under Clinton's reform plan?
    Blankenau R
    Mater Manag Health Care; 1993 Nov; 2(11):18, 20. PubMed ID: 10129563
    [No Abstract]   [Full Text] [Related]  

  • 22. Drugmaker boycott may be expanded.
    Wagner M
    Mod Healthc; 1991 Oct; 21(43):9. PubMed ID: 10114646
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug lores.
    Hesselgrave B
    Hosp Health Netw; 1996 Nov; 70(21):46-50. PubMed ID: 8939084
    [No Abstract]   [Full Text] [Related]  

  • 24. Which bottom line?
    Shane R
    Am J Hosp Pharm; 1991 Oct; 48(10):2130. PubMed ID: 1781465
    [No Abstract]   [Full Text] [Related]  

  • 25. The marketplace and health care reform: the unfinished agenda of the '90s.
    Burke G; Lewis M
    Empl Benefits J; 1995 Mar; 20(1):12-6. PubMed ID: 10142513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Railways of the nineties.
    Morrison JI
    Healthc Forum J; 1994; 37(2):30-4. PubMed ID: 10132156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Restructuring pharmacy departments for survival.
    Lazarus HL; Duncan WJ
    Am J Hosp Pharm; 1994 Nov; 51(22):2827-31. PubMed ID: 7856609
    [No Abstract]   [Full Text] [Related]  

  • 28. The response to health care reform by the pharmaceutical industry.
    Krulwich AS
    Food Drug Law J; 1995; 50(1):1-22. PubMed ID: 10342983
    [No Abstract]   [Full Text] [Related]  

  • 29. Can price and regulatory controls replace free market competition in the drug industry?
    Buc NL; Levitt GM
    Healthspan; 1993 Nov; 10(10):30-2. PubMed ID: 10130839
    [No Abstract]   [Full Text] [Related]  

  • 30. The Orphan Drug Act: an engine of innovation? At what cost?
    Rohde DD
    Food Drug Law J; 2000; 55(1):125-43. PubMed ID: 12322720
    [No Abstract]   [Full Text] [Related]  

  • 31. Merck wipes Serono off Swiss biotech map.
    Urquhart L
    Nat Biotechnol; 2006 Nov; 24(11):1303. PubMed ID: 17093457
    [No Abstract]   [Full Text] [Related]  

  • 32. Precipitating factors for pharmaceutical firms.
    McCarthy R
    State Health Care Am; 1997; ():39-43. PubMed ID: 10168083
    [No Abstract]   [Full Text] [Related]  

  • 33. [Organization of the Federal Drug and Medical Products Institute in view of increased European competition].
    Kurth R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Mar; 51(3):340-4. PubMed ID: 18369569
    [No Abstract]   [Full Text] [Related]  

  • 34. The quiet revolution.
    Nat Biotechnol; 2003 Jul; 21(7):715. PubMed ID: 12833072
    [No Abstract]   [Full Text] [Related]  

  • 35. Rethinking hospital pharmaceutical marketing.
    Zellmer WA
    Am J Health Syst Pharm; 1995 Jul; 52(14):1590. PubMed ID: 7552909
    [No Abstract]   [Full Text] [Related]  

  • 36. Replies to the question: should the practice of drug sampling be retained or eliminated?
    Hosp Formul; 1994 Oct; 29(10):720-2. PubMed ID: 10137849
    [No Abstract]   [Full Text] [Related]  

  • 37. A creditor's perspective on the hospital industry.
    Culler SD
    Top Health Care Financ; 1993; 19(4):12-20. PubMed ID: 8337688
    [No Abstract]   [Full Text] [Related]  

  • 38. Turkish hospital management at a crossroads: prospects for the year 2000.
    Tatar F; Tatar M; Sahin I; Celik Y; Ozgen H; Okem G
    J Health Adm Educ; 1998; 16(3):283-96. PubMed ID: 10339238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Back to the future. The challenges of governing community health partnerships.
    Hageman WM
    Mich Health Hosp; 1999; 35(1):35. PubMed ID: 10344823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Competitive forces in the medical group industry: a stakeholder perspective.
    Blair JD; Buesseler JA
    Health Care Manage Rev; 1998; 23(2):7-27. PubMed ID: 9595307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.